These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 38668786)

  • 1. Mechanistic complement of autosomal dominant polycystic kidney disease: the role of aquaporins.
    Lan Q; Li J; Zhang H; Zhou Z; Fang Y; Yang B
    J Mol Med (Berl); 2024 Jun; 102(6):773-785. PubMed ID: 38668786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pkd2 Deficiency in Embryonic Aqp2 + Progenitor Cells Is Sufficient to Cause Severe Polycystic Kidney Disease.
    Tsilosani A; Gao C; Chen E; Lightle AR; Shehzad S; Sharma M; Tran PV; Bates CM; Wallace DP; Zhang W
    J Am Soc Nephrol; 2024 Apr; 35(4):398-409. PubMed ID: 38254271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilia and polycystic kidney disease.
    Ma M
    Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease.
    Tan AY; Zhang T; Michaeel A; Blumenfeld J; Liu G; Zhang W; Zhang Z; Zhu Y; Rennert L; Martin C; Xiang J; Salvatore SP; Robinson BD; Kapur S; Donahue S; Bobb WO; Rennert H
    J Am Soc Nephrol; 2018 Aug; 29(8):2139-2156. PubMed ID: 30042192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of aquaporins-1 and -2 during nephrogenesis and in autosomal dominant polycystic kidney disease.
    Devuyst O; Burrow CR; Smith BL; Agre P; Knepper MA; Wilson PD
    Am J Physiol; 1996 Jul; 271(1 Pt 2):F169-83. PubMed ID: 8760258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing.
    Alzahrani OR; Alatwi HE; Alharbi AA; Alessa AH; Al-Amer OM; Alanazi AFR; Shams AM; Alomari E; Naser AY; Alzahrani FA; Hosawi S; Alghamdi SM; Abdali WA; Elfaki I; Hawsawi YM
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.
    Wu G
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):23-31. PubMed ID: 11195048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology, epidemiology, clinical presentation, diagnosis and treatment options for autosomal dominant polycystic kidney disease].
    Noël N; Rieu P
    Nephrol Ther; 2015 Jul; 11(4):213-25. PubMed ID: 26113401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal recessive and dominant polycystic kidney diseases.
    Sessa A; Righetti M; Battini G
    Minerva Urol Nefrol; 2004 Dec; 56(4):329-38. PubMed ID: 15785425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease.
    Wu G; Tian X; Nishimura S; Markowitz GS; D'Agati V; Park JH; Yao L; Li L; Geng L; Zhao H; Edelmann W; Somlo S
    Hum Mol Genet; 2002 Aug; 11(16):1845-54. PubMed ID: 12140187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of PKD1 and PKD2 Somatic Variants in Autosomal Dominant Polycystic Kidney Cyst Epithelial Cells by Whole-Genome Sequencing.
    Zhang Z; Bai H; Blumenfeld J; Ramnauth AB; Barash I; Prince M; Tan AY; Michaeel A; Liu G; Chicos I; Rennert L; Giannakopoulos S; Larbi K; Hughes S; Salvatore SP; Robinson BD; Kapur S; Rennert H
    J Am Soc Nephrol; 2021 Dec; 32(12):3114-3129. PubMed ID: 34716216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
    Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
    J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of DNA damage as a therapeutic target in autosomal dominant polycystic kidney disease.
    Zhang JQJ; Saravanabavan S; Munt A; Wong ATY; Harris DC; Harris PC; Wang Y; Rangan GK
    Expert Rev Mol Med; 2019 Nov; 21():e6. PubMed ID: 31767049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
    Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
    BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.
    Sundar SV; Zhou JX; Magenheimer BS; Reif GA; Wallace DP; Georg GI; Jakkaraj SR; Tash JS; Yu ASL; Li X; Calvet JP
    Am J Physiol Renal Physiol; 2022 Oct; 323(4):F492-F506. PubMed ID: 35979967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD).
    Nikonova AS; Deneka AY; Kiseleva AA; Korobeynikov V; Gaponova A; Serebriiskii IG; Kopp MC; Hensley HH; Seeger-Nukpezah TN; Somlo S; Proia DA; Golemis EA
    FASEB J; 2018 May; 32(5):2735-2746. PubMed ID: 29401581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene.
    Abdelwahed M; Hilbert P; Ahmed A; Mahfoudh H; Bouomrani S; Dey M; Hachicha J; Kamoun H; Keskes-Ammar L; Belguith N
    Gene; 2018 Sep; 671():28-35. PubMed ID: 29860066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of autosomal dominant polycystic kidney disease.
    Al-Bhalal L; Akhtar M
    Adv Anat Pathol; 2005 May; 12(3):126-33. PubMed ID: 15900113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions.
    Malekshahabi T; Khoshdel Rad N; Serra AL; Moghadasali R
    J Cell Physiol; 2019 Aug; 234(8):12451-12470. PubMed ID: 30644092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.
    Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR
    Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.